Stay updated on Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added a Locations section displaying Texas as a study location and removed the Texas Locations and HHS Vulnerability Disclosure links.
    Difference
    0.2%
    Check dated 2025-12-23T13:33:47.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2, with no changes to study content or core functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:53:17.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added 'Results Submitted' to indicate that study results are available; removed the funding lapse notice and the 'No Results Posted' message.
    Difference
    0.4%
    Check dated 2025-11-17T17:48:37.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The study record NCT03873818 on ClinicalTrials.gov was updated with a new last update date (2025-04-27) and current enrollment status.
    Difference
    0.4%
    Check dated 2025-11-03T12:32:43.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Update includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment status and the presence of temporary funding-related notices; the previous version tag (v3.1.0) was removed.
    Difference
    3%
    Check dated 2025-10-05T16:43:22.000Z thumbnail image
  9. Check
    105 days ago
    Change Detected
    Summary
    Significant expansion of immune-related terminology and an explicit version upgrade to v3.1.0. Older version v3.0.2 is removed.
    Difference
    0.9%
    Check dated 2025-09-28T09:52:20.000Z thumbnail image

Stay in the know with updates to Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.